OAT-IN-2
OAT-IN-2 is an ornithine aminotransferase (hOAT) inhibitor. OAT-IN-2 is used in the research of hepatocellular carcinoma.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 3057206-96-6
- 화학식: C7H9F2NO2
- 분자량:177.15
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
In Vitro
OAT-IN-2 (Compound 5) is a time-dependent inhibitor of hOAT with a kinact/KI of 0.219 mM-1 min-1[1].
OAT-IN-2 (2-18 equiv; 72 h) irreversibly inhibits hOAT, as no enzymatic activity was recovered after 72 h of dialysis[1].
OAT-IN-2 forms a noncovalent, tight-binding adduct with hOAT[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 3057206-96-6
-
분자량 177.15
-
화학식 C7H9F2NO2
-
SMILES
O=C([C@]12C[C@H](N)C[C@@]1([H])C2(F)F)O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)